Clinical Trial Update: Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase I/II trial evaluating CPX-351 in combination with palbociclib for acute myeloid leukemia have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CPX-351 (liposomal daunorubicin/cytarabine)
• Palbociclib (palbociclib)

Snippet

Sponsor: Sudipto Mukherjee, MD, PhD, MPH | Conditions: Acute Myeloid Leukemia, AML | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-31